Aimmune wins approval for peanut immunotherapy, charges 10k+

Aimmune wins approval for peanut immunotherapy, charges 10k+

Source: 
Endpoints
snippet: 

The FDA has approved the first treatment for peanut allergy, although it comes with some controversy.

Unlike most of the controversial drugs that come before the FDA, the bulk of questions don’t center around this drug’s effectiveness or side effects.